| Oct 23 |
Rhythm Pharmaceuticals to Report Third Quarter 2024 Financial Results on Tuesday, November 5, 2024
|
| Oct 21 |
Top small-cap stock picks from Morgan Stanley following the group's upgrade to neutral
|
| Oct 14 |
High Growth Tech Stocks to Watch in October 2024
|
| Sep 22 |
Rhythm: Upcoming sNDA Label Expansion IMCIVREE Isn't The Only Catalyst On Deck
|
| Sep 21 |
Rhythm Pharmaceuticals, Inc. (RYTM): Short Seller Sentiment is Bearish
|
| Sep 18 |
Strength Seen in Rhythm Pharmaceuticals (RYTM): Can Its 7.4% Jump Turn into More Strength?
|
| Sep 17 |
Rhythm Pharma draws bullish view at JMP on opportunity in rare genetic obesities
|
| Sep 10 |
Biotech Stock Near Buy Point Amid Impressive Sales Track Record
|
| Sep 6 |
Four Biotech Stocks Rally Toward Buy Points As Funds Load Up
|
| Aug 29 |
Rhythm: Pivotal Moment Approaching In Hypothalamic Obesity (Rating Upgrade)
|
